Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Biological Chemistry|November 24, 2004
Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activityNaila Ahmed, Darin Dobler, Mark Dean, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 8, 2010
Testing the reward prediction error hypothesis with an axiomatic modelRobb B Rutledge, Mark Dean, Andrew Caplin, et al.
The Quarterly Journal of Economics|July 15, 2014
MEASURING BELIEFS AND REWARDS: A NEUROECONOMIC APPROACHAndrew Caplin, Mark Dean, Paul W Glimcher, et al.
Blood Transfusion = Trasfusione Del Sangue|December 2, 2020
Investigating the association between blood transfusion and clinical outcomes in patients with acute coronary syndromes: a data linkage approach to Patient Blood ManagementGuilherme S Franco, Julie Li, Ling Li, et al.
Clinical Orthopaedics and Related Research|December 4, 2004
A soft tissue attempt to stabilize the multiply operated glenohumeral joint with multidirectional instabilitySumant G Krishnan, Richard J Hawkins, Marilee P Horan, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 12, 2006
Coccygeoplasty: treatment for fractures of the coccyxL Mark Dean, Mubin I Syed, Solomon A Jan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 23, 2004
Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigationEmmanuel J Favaloro, Jennifer Posen, Raj Ramakrishna, et al.
Mayo Clinic Proceedings. Digital Health|July 3, 2026
Real-World Validation of PinPoint Blood Tests in the NHS: Multivariable Machine Learning to Predict Cancer Risk in Primary Care Urgent ReferralsMatt Neal, Mark Dean, Sean Duffy, et al.
British Journal of Cancer|September 11, 2018
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinomaThomas Powles, Robert J Motzer, Bernard Escudier, et al.
Pageof 2